These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8828023)

  • 41. Antihistamines in severe/chronic rhinitis.
    Bousquet J
    Clin Exp Allergy; 1998 Dec; 28 Suppl 6():49-53. PubMed ID: 9988436
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
    Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
    Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Efficacy and safety of bilastine 20 mg compared with cetirizine 10 mg and placebo for the symptomatic treatment of seasonal allergic rhinitis: a randomized, double-blind, parallel-group study.
    Kuna P; Bachert C; Nowacki Z; van Cauwenberge P; Agache I; Fouquert L; Roger A; Sologuren A; Valiente R;
    Clin Exp Allergy; 2009 Sep; 39(9):1338-47. PubMed ID: 19438584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Once-daily cetirizine effective in the treatment of seasonal allergic rhinitis in children aged 6 to 11 years: a randomized, double-blind, placebo-controlled study.
    Pearlman DS; Lumry WR; Winder JA; Noonan MJ
    Clin Pediatr (Phila); 1997 Apr; 36(4):209-15. PubMed ID: 9114992
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of cetirizine, ebastine and loratadine in the treatment of immediate mosquito-bite allergy.
    Karppinen A; Kautiainen H; Petman L; Burri P; Reunala T
    Allergy; 2002 Jun; 57(6):534-7. PubMed ID: 12028119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized, double-blind, placebo-controlled study comparing the efficacy and safety of ebastine (20 mg and 10 mg) to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis.
    Hampel F; Howland W; Van Bavel J; Ratner P
    J Investig Allergol Clin Immunol; 2004; 14(1):56-63. PubMed ID: 15160443
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of topical corticosteroid and combined mediator blockade on domiciliary and laboratory measurements of nasal function in seasonal allergic rhinitis.
    Wilson AM; Sims EJ; Orr LC; Coutie WJ; White PS; Gardiner Q; Lipworth BJ
    Ann Allergy Asthma Immunol; 2001 Oct; 87(4):344-9. PubMed ID: 11686428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical study of the therapeutic efficacy and safety of emedastine difumarate versus cetirizine in the treatment of seasonal allergic rhinitis.
    Horak F; Stübner P; Zieglmayer R; Kavina A; Corrado ME; Assandri A; Mion A
    Arzneimittelforschung; 2004; 54(10):666-72. PubMed ID: 15553106
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children.
    Simons FE; Johnston L; Simons KJ
    Pediatr Allergy Immunol; 2000 May; 11(2):116-9. PubMed ID: 10893015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The efficacy and tolerability of two novel H(1)/H(3) receptor antagonists in seasonal allergic rhinitis.
    Daley-Yates P; Ambery C; Sweeney L; Watson J; Oliver A; McQuade B
    Int Arch Allergy Immunol; 2012; 158(1):84-98. PubMed ID: 22212854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levocetirizine: new preparation. Me-too: simply the active enantiomer of cetirizine.
    Prescrire Int; 2003 Oct; 12(67):171-2. PubMed ID: 14619884
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fexofenadine hydrochloride, 180 mg, exhibits equivalent efficacy to cetirizine, 10 mg, with less drowsiness in patients with moderate-to-severe seasonal allergic rhinitis.
    Hampel F; Ratner P; Mansfield L; Meeves S; Liao Y; Georges G
    Ann Allergy Asthma Immunol; 2003 Oct; 91(4):354-61. PubMed ID: 14582814
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Double-blind study of cetirizine and loratadine versus placebo in patients with allergic rhinitis.
    Nunes C; Ladeira S
    J Investig Allergol Clin Immunol; 2000; 10(1):20-3. PubMed ID: 10780795
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison between nasal provocation tests and skin tests in patients treated with loratadine and cetirizine.
    Persi L; Demoly P; Harris AG; Tisserand B; Michel FB; Bousquet J
    J Allergy Clin Immunol; 1999 Apr; 103(4):591-4. PubMed ID: 10200006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Meta-analysis of the efficacy of ebastine 20 mg compared to loratadine 10 mg and placebo in the symptomatic treatment of seasonal allergic rhinitis.
    Ratner P; Falqués M; Chuecos F; Esbrí R; Gispert J; Peris F; Luria X; Rosales MJ
    Int Arch Allergy Immunol; 2005 Dec; 138(4):312-8. PubMed ID: 16224195
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of the effects of cetirizine and ebastine on the skin response to histamine iontophoresis monitored with laser Doppler flowmetry.
    Leroy T; Tasset C; Valentin B; Van Neste D
    Dermatology; 1998; 197(2):146-51. PubMed ID: 9732164
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
    Antonijoan RM; García-Gea C; Puntes M; Valle M; Esbri R; Fortea J; Barbanoj MJ
    Clin Drug Investig; 2007; 27(7):453-61. PubMed ID: 17563125
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Astemizole and cetirizine in the treatment of seasonal allergic rhinitis: a comparative double-blind, multicentre study.
    Rijntjes E; Ghys L; Rihoux JP
    J Int Med Res; 1990; 18(3):219-24. PubMed ID: 1972927
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of cetirizine in the treatment of seasonal allergic rhinoconjunctivitis.
    Panayotopoulos SM; Panayotopoulou ES
    Ann Allergy; 1990 Aug; 65(2):146-8. PubMed ID: 1974401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long QT syndrome in a patient with allergic rhinoconjunctivitis and auto-immune diabetes: focus on the choice of anti-H1 drugs.
    Moneret-Vautrin DA; de Chillou C; Codreanu A
    Eur Ann Allergy Clin Immunol; 2006 Dec; 38(10):347-50. PubMed ID: 17274518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.